Preparing Vaccine Studies for Regulatory Submissions

The COVID-19 pandemic had an immense impact on people’s lives. The quick development of effective and safe vaccines as well as their availability are critical to public health.

Clinical trials for vaccines typically collect similar types of data. Preparing this data for submission requires knowledge of specific guidance from regulatory agencies and standards development organizations. In this webinar, Michael Beers reviews FDA, PMDA, and CDISC guidance and other considerations for preparing vaccine studies for regulatory submissions. Also, Michael goes over common problems and inconsistencies seen in data of vaccine studies.

Need more help with preparing vaccine studies for regulatory submissions?

If you have questions or need expert guidance, Michael Beers and our team are here to help. Contact us today to navigate the challenges with confidence.

お問合せはこちら